NEOVACS
Biotechnology Research • 
Suresnes, Île-de-France, France • 11-20 Employees
Company overview
| Headquarters | 14, Rue de la République, Suresnes, Île-de-France 92150, FR |
| Phone number | +33153109300 |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Active Immunotherapies And Therapeutic Vaccine |
| Employees | 11-20 |
| Socials |
Key Contact at NEOVACS
Olivier Dhellin
Director Pharmaceutical Development
NEOVACS Email Formats
NEOVACS uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@neovacs.com), used 88.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@neovacs.com | 88.9% |
{first initial}{last name} | jdoe@neovacs.com | 11.1% |
About NEOVACS
Neovacs, a French Biotechnology company, develops therapeutic vaccines for the treatment of autoimmune, inflammatory diseases aand invests in innovative companies (Biotech and Medtech).
NEOVACS revenue & valuation
| Annual revenue | $1,368,880 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,400,000 |
| Total funding | $6,460,399 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
NEOVACS has 7 employees across 2 departments.
Departments
Number of employees
Funding Data
Explore NEOVACS's funding history, including investment rounds, total capital raised, and key backers.
NEOVACS Tech Stack
Discover the technologies and tools that power NEOVACS's digital infrastructure, from frameworks to analytics platforms.
Mobile frameworks
Web servers
CMS
Security
UI frameworks
JavaScript libraries
Tag managers
Programming languages
Security
Font scripts
SSL/TLS certificate authorities
Hosting
United Kingdom
Japan
Germany
Iran, Islamic Republic of
United States
Frequently asked questions
4.8
40,000 users
